Clinical Trials on Healthy Volunteers in Belgium

Total 642 results

Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG1972

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG2222

Healthy

Belgium
Brugmann University Hospital

Completed

The Mineral Water of Vichy and the Urinary Alkalization: A Study of the Dose - Effect of Bicarbonate Salt Water on the Urinary pH in Healthy Volunteers

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Drug Interaction Study to Assess the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults

Healthy

Belgium
Pfizer

Completed

A Study Comparing Amounts of Tafamidis In The Blood With Or Without Food

Healthy

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Efficacity of Incentive Spirometry in Elderly People

Healthy

Belgium
Pfizer

Completed

A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions

Healthy

Belgium
Galapagos NV

Completed

A Phase I, Open Interaction Study Between GLPG1837 and Midazolam in Healthy Male Subjects

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy Participants

Healthy

Belgium
Genfit
SGS Life Sciences, a division of SGS Belgium NV

Completed

Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers

Healthy

Belgium
Janssen Research & Development, LLC

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42165279 in Healthy Young and Elderly Participants

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Pharmacokinetic, Safety and Tolerability Study of Esketamine in Healthy Elderly and Adult Participants

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers

Healthy

Belgium
Janssen Pharmaceutica N.V., Belgium

Completed

A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of JNJ-42165279 in Healthy Male Participants

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy Volunteers

Healthy

Belgium
Janssen R&D Ireland

Completed

A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Volunteers

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male Participants

Healthy

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Evaluation of Correct PEP Use With the Time

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG1205

Healthy

Belgium
Pfizer

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects

Healthy

Belgium
Galapagos NV

Completed

Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single Ascending and Multiple Dose of GLPG0259

Healthy

Belgium
Pfizer

Completed

Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single Ascending and Multiple Dose of GLPG0778

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single Ascending and Multiple Dose of GLPG0634

Healthy

Belgium
Galapagos NV

Completed

Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects

Healthy

Belgium
Pfizer

Completed

A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Following A Single Dose Of PF-04995274 In Healthy Adult Volunteers

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single Ascending and Multiple Dose of GLPG0555

Healthy

Belgium
Pfizer

Completed

A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers

Healthy

Belgium
University Ghent
VIB

Completed

Study of the Effect of Lactisole on the Intestinal Glucose Uptake

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Safety and Tolerability Study of JNJ-72537634 in Healthy Participants

Healthy

Belgium
Boehringer Ingelheim

Active, not recruiting

A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin

Healthy

Belgium
Boehringer Ingelheim

Completed

Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy Subjects

Healthy

Belgium
Boehringer Ingelheim

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers

Healthy

Belgium
Boehringer Ingelheim

Completed

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single Ascending Dose of GLPG0492

Healthy

Belgium
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated

Healthy

Belgium
University Ghent

Completed

The Impact of Blood Flow Restriction Within Warm-up.

Healthy

Belgium
Boehringer Ingelheim

Completed

A Study to Test How Well Different Doses of BI 765845 Are Tolerated by Healthy People

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult Participants

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge

Healthy

Belgium
Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers

Healthy

Belgium
Actelion

Completed

A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and Tadalafil

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants

Healthy

Belgium
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 765080 is Taken up in the Body When Given as an Injection Under the Skin Compared With an Infusion Into the Vein

Healthy

Belgium
Janssen Research & Development, LLC

Completed

A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2

Healthy

Belgium

3

Subscribe